Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Asian Cardiovascular & Thoracic Annals
|
February 27, 2014
One-way endobronchial valve for bronchopleural fistula after necrotizing pneumonia
Tomas Gudbjartsson, Solveig Helgadottir, Lars Ek
Lakartidningen
|
February 23, 2013
[Bronchopleural fistula treated with endobronchial vent placement. Successful treatment of feared lung complication]
Gerdt C Riise, Gunnar Hillerdal, Lars Ek
The Laryngoscope
|
April 6, 2004
Prevalence of olfactory dysfunction: the skövde population-based study
Annika Brämerson, Leif Johansson, Lars Ek, et al.
The Clinical Respiratory Journal
|
June 10, 2011
Diagnostic yield and efficacy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymphadenopathy
Björn Jernlås, Henrik Nyberger, Lars Ek, et al.
Plos One
|
February 2, 2022
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
Marija Karadzovska-Kotevska, Hans Brunnström, Jaroslaw Kosieradzki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2012
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
Sverre Sörenson, Helena Fohlin, Andrea Lindgren, et al.
The European Respiratory Journal
|
May 5, 2012
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Felix J F Herth, Ralf Eberhardt, Daniela Gompelmann, et al.
Cancers
|
March 10, 2022
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
Emelie Gezelius, Pär-Ola Bendahl, Widet Gallo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2011
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
Andrea Koch, Bengt Bergman, Erik Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 16, 2017
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer
Miklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Asian Cardiovascular & Thoracic Annals
|
February 27, 2014
One-way endobronchial valve for bronchopleural fistula after necrotizing pneumonia
Tomas Gudbjartsson, Solveig Helgadottir, Lars Ek
Lakartidningen
|
February 23, 2013
[Bronchopleural fistula treated with endobronchial vent placement. Successful treatment of feared lung complication]
Gerdt C Riise, Gunnar Hillerdal, Lars Ek
The Laryngoscope
|
April 6, 2004
Prevalence of olfactory dysfunction: the skövde population-based study
Annika Brämerson, Leif Johansson, Lars Ek, et al.
The Clinical Respiratory Journal
|
June 10, 2011
Diagnostic yield and efficacy of endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal lymphadenopathy
Björn Jernlås, Henrik Nyberger, Lars Ek, et al.
Plos One
|
February 2, 2022
Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience
Marija Karadzovska-Kotevska, Hans Brunnström, Jaroslaw Kosieradzki, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2012
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
Sverre Sörenson, Helena Fohlin, Andrea Lindgren, et al.
The European Respiratory Journal
|
May 5, 2012
Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment
Felix J F Herth, Ralf Eberhardt, Daniela Gompelmann, et al.
Cancers
|
March 10, 2022
Circulating Levels of the Cardiovascular Biomarkers ST2 and Adrenomedullin Predict Outcome within a Randomized Phase III Lung Cancer Trial (RASTEN)
Emelie Gezelius, Pär-Ola Bendahl, Widet Gallo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 14, 2011
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: a double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
Andrea Koch, Bengt Bergman, Erik Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)
|
November 16, 2017
COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer
Miklos Gulyas, Johanna Sofia Margareta Mattsson, Andrea Lindgren, et al.
Page
of 2